Loading company…
Won a federal SBIR/STTR research award from NSF and other federal agencies.
HISTONE THERAPEUTICS has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $273,388 in 2023. These are non-dilutive federal research grants, not equity financing. The company is based in SEATTLE, Washington.
No investors recorded yet for HISTONE THERAPEUTICS.
Add an investorHISTONE THERAPEUTICS has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for HISTONE THERAPEUTICS.
Add diversity data